Rui Liu, Zhi Ji, Xia Wang. "Phase Ib/II clinical study of adebrelimab combined with decitabine, nab-paclitaxel, and gemcitabine as first-line (IL) treatment for metastatic pancreatic cancer (mPC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4200